Eaton Vance Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,517
Closed -$121K 1869
2021
Q4
$121K Buy
3,517
+1,410
+67% +$45.6K ﹤0.01% 1757
2021
Q3
$26K Sell
2,107
-36
-2% -$1.22K ﹤0.01% 1606
2021
Q2
$78K Buy
2,143
+1,288
+151% +$53.3K ﹤0.01% 1999
2021
Q1
$37K Buy
+855
New +$40.1K ﹤0.01% 1864
2015
Q4
Sell
-8,772
Closed -$249K 941
2015
Q3
$249K Buy
+8,772
New +$306K ﹤0.01% 879
2015
Q2
Sell
-4,164
Closed -$205K 927
2015
Q1
$205K Sell
4,164
-714
-15% -$33.1K ﹤0.01% 913
2014
Q4
$222K Buy
+4,878
New +$192K ﹤0.01% 880

Other funds holding AVNS

Eaton Vance Management's AVNS Position: Q1 2022 in Review

Eaton Vance Management sold out of Avanos Medical (AVNS) in Q1 2022, closing a stake of 3,517 shares — an estimated $121K sold.

Eaton Vance Management first reported a position in AVNS in Q4 2014 and held it in 7 quarters. The position peaked at $249K in Q3 2015. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

  • Eaton Vance Management reported no remaining Avanos Medical position as of Q1 2022 after selling out during the quarter.
  • Eaton Vance Management sold 3,517 Avanos Medical shares in Q1 2022, an estimated $121K.
  • Eaton Vance Management first reported a position in Avanos Medical in Q4 2014 and held it in 7 quarters.
  • Eaton Vance Management's Avanos Medical position peaked at $249K in Q3 2015.
  • 299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.